Brainever

Description

Develops novel biopharmaceutical therapies to halt neurodegenerative disease progression; used for patients with ALS, Parkinson’s disease, and retinal neurodegenerative conditions.

Related

• Herantis Pharma OyjHerantis Pharma develops therapies for neurodegenerative diseases.
• BioArctic ABDevelops disease-modifying treatments and research programs for neurodegenerative disorders, specifically focusing on Alzheimer’s disease…
• German Center for Neurodegenerative DiseasesA research institute studying neurodegenerative diseases and developing strategies for prevention, diagnosis, care and treatment for…
• Agomab TherapeuticsAgomab develops biopharmaceutical therapies for fibro-inflammatory conditions, targeting the TGFß/ALK5 pathway and advancing candidates for…
• Aenitis TechnologiesDevelops devices and consumables using patented acoustic levitation for contact-free cell handling; used by bioprocessing workflows and…
• Hansa Biopharma ABDevelops immunomodulating therapies using antibody-cleaving enzyme technology for patients with rare IgG-driven immunologic conditions, and…
• INBRAIN NEUROELECTRONICSINBRAIN Neuroelectronics develops graphene-based brain-computer interface technology.
• RobeautéBuilds a microrobotic platform intended to improve surgery; used for understanding and treating brain disease and supporting neurosurgery…
• Isomorphic LabsBuilds predictive and generative AI models for drug discovery, used to accelerate scientific discovery and design novel molecules for…
• Aspen NeuroscienceDevelops autologous iPSC-derived cell therapies using a patient’s own cells, initially targeting Parkinson’s disease by replacing lost…
• Newronika SPABuilds an adaptive deep brain stimulation system that senses neural signals and adjusts therapy in real time; used by physicians to…
• CorWave SADevelops implantable left ventricular assist pumps using a wave membrane to provide truly pulsatile blood flow for patients with advanced…